Valuation Shijiazhuang Yiling Pharmaceutical Co., Ltd.

Equities

End-of-day quote Shenzhen S.E. Other stock markets 2024-09-12			5-day change	1st Jan Change
14.86 ^CNY	-0.87%		-3.38%	-35.59%

08-27	Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	CI
07-12	Shijiazhuang Yiling Pharmaceutical Co., Ltd. Implements Cash Dividend for the Year 2023, Payable on 19 July 2024	CI

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	14,801	30,365	32,746	50,054	38,543	24,827	-	-
Change	-	105.15%	7.84%	52.86%	-23%	-35.59%	-	-
Enterprise Value (EV) ¹	14,801	30,365	32,746	49,007	39,009	24,313	23,284	22,500
Change	-	105.15%	7.84%	49.66%	-20.4%	-37.67%	-4.23%	-3.37%
P/E ratio	24.9x	25x	24.4x	21.2x	28.5x	18.7x	16.1x	13.8x
PBR	1.88x	3.44x	3.61x	4.58x	3.37x	1.98x	1.79x	1.62x
PEG	-	0x	2.3x	0.3x	-0.7x	-10.77x	1x	0.8x
Capitalization / Revenue	2.54x	3.46x	3.24x	3.99x	3.74x	2.39x	2.12x	1.88x
EV / Revenue	2.54x	3.46x	3.24x	3.91x	3.78x	2.34x	1.99x	1.7x
EV / EBITDA	15.2x	17.7x	16.9x	15x	16.8x	10.2x	8.81x	7.55x
EV / EBIT	20.8x	21.1x	20.9x	17.3x	21.9x	14.6x	12.2x	10.1x
EV / FCF	-	68,745,950x	-	-	-	-	-	-
FCF Yield	-	0%	-	-	-	-	-	-
Dividend per Share ²	0.1429	0.7143	0.3	0.5	0.3	0.1559	0.1746	0.195
Rate of return	1.61%	3.92%	1.53%	1.67%	1.3%	1.05%	1.17%	1.31%
EPS ²	0.3571	0.7286	0.8044	1.414	0.8095	0.7954	0.9238	1.075
Distribution rate	40%	98%	37.3%	35.4%	37.1%	19.6%	18.9%	18.1%
Net sales ¹	5,825	8,782	10,117	12,533	10,318	10,393	11,701	13,223
EBITDA ¹	973.9	1,713	1,939	3,271	2,321	2,385	2,642	2,978
EBIT ¹	710.2	1,438	1,569	2,830	1,780	1,670	1,916	2,230
Net income ¹	606.5	1,219	1,344	2,362	1,352	1,332	1,543	1,795
Net Debt ¹	-	-	-	-1,048	465.6	-513.5	-1,542	-2,327
Reference price ²	8.88	18.21	19.60	29.96	23.07	14.86	14.86	14.86
Nbr of stocks (in thousands)	1,667,081	1,667,081	1,670,705	1,670,705	1,670,705	1,670,705	-	-
Announcement Date	20-02-27	21-02-25	22-04-28	23-04-25	24-04-26	-	-	-

¹CNY in Million²CNY

Estimates

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E ratio	EV / Sales	EV / EBITDA	Yield (Y)	Capi. ($)
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	18.84x	2.36x	10.29x	+1.04%	3.52B
DONG-E-E-JIAO CO.,LTD.	20.76x	4.4x	14.63x	+4.69%	4.19B
TASLY PHARMACEUTICAL GROUP CO., LTD	17.24x	2.12x	9.5x	+2.67%	2.9B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	18.11x	-	-	-.--%	2.57B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	16.39x	2.64x	12.13x	+4.57%	1.59B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	17.67x	-	-	-	1.34B
PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK	17.48x	4.86x	12.39x	+4.93%	1.32B
Average	18.07x	3.28x	11.79x	+2.98%	2.49B
Weighted average by Cap.	18.51x	3.22x	11.89x	+2.79%